A detailed history of Bank Julius Baer & Co. Ltd, Zurich transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Bank Julius Baer & Co. Ltd, Zurich holds 95,464 shares of EW stock, worth $7.08 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
95,464
Previous 933,461 89.77%
Holding current value
$7.08 Million
Previous $86.2 Million 92.69%
% of portfolio
0.02%
Previous 0.36%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$59.7 - $93.78 $50 Million - $78.6 Million
-837,997 Reduced 89.77%
95,464 $6.3 Million
Q2 2024

Aug 14, 2024

SELL
$84.3 - $94.31 $5.12 Million - $5.73 Million
-60,713 Reduced 6.11%
933,461 $86.2 Million
Q1 2024

May 14, 2024

BUY
$72.54 - $95.56 $14.5 Million - $19.1 Million
199,563 Added 25.11%
994,174 $95 Million
Q4 2023

May 16, 2024

SELL
$61.71 - $77.76 $51.1 Million - $64.4 Million
-827,824 Reduced 83.27%
166,350 $12.7 Million
Q4 2023

May 16, 2024

BUY
$61.71 - $77.76 $38.8 Million - $48.9 Million
628,261 Added 377.67%
794,611 $60.6 Million
Q4 2023

Feb 02, 2024

BUY
$61.71 - $77.76 $123,420 - $155,520
2,000 Added 0.25%
794,611 $60.6 Million
Q3 2023

Nov 13, 2023

BUY
$69.28 - $93.38 $2.31 Million - $3.11 Million
33,296 Added 4.39%
792,611 $54.9 Million
Q2 2023

Jul 24, 2023

BUY
$81.41 - $94.33 $61.8 Million - $71.6 Million
759,315 New
759,315 $71.6 Million
Q1 2023

May 11, 2023

SELL
$74.26 - $84.51 $553,608 - $630,022
-7,455 Reduced 0.96%
767,479 $63.5 Million
Q4 2022

Jan 24, 2023

SELL
$68.3 - $87.44 $1,229 - $1,573
-18 Reduced -0.0%
774,934 $57.8 Million
Q3 2022

Nov 04, 2022

SELL
$82.37 - $107.29 $3.56 Million - $4.63 Million
-43,197 Reduced 5.28%
774,952 $64 Million
Q2 2022

Jul 22, 2022

SELL
$86.5 - $128.27 $84.5 Million - $125 Million
-977,446 Reduced 54.44%
818,149 $77.8 Million
Q1 2022

May 09, 2022

BUY
$101.96 - $128.34 $4.72 Million - $5.94 Million
46,253 Added 2.64%
1,795,595 $211 Million
Q4 2021

Feb 15, 2022

BUY
$106.37 - $130.68 $19.4 Million - $23.8 Million
182,080 Added 11.62%
1,749,342 $227 Million
Q3 2021

Nov 12, 2021

BUY
$102.91 - $122.75 $19.5 Million - $23.2 Million
189,189 Added 13.73%
1,567,262 $177 Million
Q2 2021

Jul 23, 2021

BUY
$83.84 - $104.76 $33.6 Million - $42 Million
400,567 Added 40.98%
1,378,073 $143 Million
Q1 2021

May 10, 2021

SELL
$78.68 - $90.67 $18.4 Million - $21.2 Million
-233,992 Reduced 19.31%
977,506 $81.8 Million
Q4 2020

Feb 24, 2021

BUY
$71.69 - $91.23 $57.8 Million - $73.6 Million
806,882 Added 199.42%
1,211,498 $111 Million
Q4 2020

Feb 12, 2021

SELL
$71.69 - $91.23 $45.6 Million - $58 Million
-635,403 Reduced 61.1%
404,616 $111 Million
Q3 2020

Nov 10, 2020

BUY
$67.19 - $87.44 $8.65 Million - $11.3 Million
128,744 Added 14.13%
1,040,019 $83 Million
Q2 2020

Aug 12, 2020

BUY
$57.54 - $76.95 $36.4 Million - $48.7 Million
632,406 Added 226.78%
911,275 $63 Million
Q1 2020

May 13, 2020

BUY
$52.41 - $81.0 $14.6 Million - $22.6 Million
278,869 New
278,869 $52.4 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $45.8B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Bank Julius Baer & Co. Ltd, Zurich Portfolio

Follow Bank Julius Baer & Co. Ltd, Zurich and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

News

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.